Daniel Brigot

Title: The Innovative Contributions of Daniel Brigot

Introduction

Daniel Brigot is a notable inventor based in Sainte-Marie-des-Champs, France. He has made significant contributions to the field of medicinal chemistry, particularly in the synthesis of compounds used in pharmaceuticals. With a total of 7 patents to his name, Brigot's work has had a considerable impact on the development of important medicinal products.

Latest Patents

Brigot's latest patents include a process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one, which has applications in the synthesis of ivabradine and its addition salts with pharmaceutically acceptable acids. He has also developed processes for synthesizing ivabradine in various forms, including its crystalline hydrochloride form. These innovations are particularly useful as bradycardics, which are medications that slow down the heart rate.

Career Highlights

Throughout his career, Brigot has worked with prominent companies in the pharmaceutical industry, including Les Laboratoires Servier. His expertise in medicinal chemistry has allowed him to contribute to the development of various therapeutic agents. His work has been recognized for its potential to improve patient outcomes in cardiovascular health.

Collaborations

Brigot has collaborated with esteemed colleagues such as Jean-Michel Lerestif and Jean-Pierre Lecouve. These partnerships have fostered a collaborative environment that has led to innovative solutions in the field of medicinal chemistry.

Conclusion

Daniel Brigot's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of important pharmaceutical compounds.